Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Disopyramide | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Disopyramide | hsa00190 | Oxidative phosphorylation | 7.38E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Disopyramide | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Disopyramide | hsa00620 | Pyruvate metabolism | 4.20E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Disopyramide | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Disopyramide | hsa00830 | Retinol metabolism | 4.25E-02 | 1 | P00325 | ADH1B | More | | Disopyramide | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Disopyramide | hsa00983 | Drug metabolism - other enzymes | 2.07E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Disopyramide | hsa01100 | Metabolic pathways | 4.56E-02 | 11 | P15144, P32320, P06280, P24666, P33121, P42330, Q13093, Q9NY28, Q9BX95, P09960, Q16718 | ANPEP, CDA, GLA, ACP1, ACSL1, AKR1C3, PLA2G7, GALNT8, SGPP1, LTA4H, NDUFA5 | More | | Disopyramide | hsa01522 | Endocrine resistance | 4.07E-04 | 5 | P14780, P22694, Q9UM47, P10415, Q13323 | MMP9, PRKACB, NOTCH3, BCL2, BIK | More | | Disopyramide | hsa03010 | Ribosome | 4.27E-07 | 17 | P62753, P42677, P25398, P32969, P40429, P62917, P62829, P46776, Q9H0U6, Q07020, P62910, P18077, Q02878, P36578, P05386, P62249, P23396 | RPS6, RPS27, RPS12, RPL9, RPL13A, RPL8, RPL23, RPL27A, MRPL18, RPL18, RPL32, RPL35A, RPL6, RPL4, RPLP1, RPS16, RPS3 | More | | Disopyramide | hsa03015 | mRNA surveillance pathway | 1.83E-02 | 3 | Q13362, Q14738, Q9UBU9 | PPP2R5C, PPP2R5D, NXF1 | More | | Disopyramide | hsa03020 | RNA polymerase | 3.25E-06 | 4 | P30876, P62487, Q9GZM3, P52435 | POLR2B, POLR2G, POLR2J2, POLR2J | More | | Disopyramide | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Disopyramide | hsa04024 | cAMP signaling pathway | 1.53E-02 | 4 | P49019, P22694, P20020, P48058 | HCAR3, PRKACB, ATP2B1, GRIA4 | More | | Disopyramide | hsa04071 | Sphingolipid signaling pathway | 1.70E-03 | 5 | Q9H228, P01375, Q13362, Q9BX95, P10415 | EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Disopyramide | hsa04114 | Oocyte meiosis | 3.65E-02 | 3 | P0DP23, Q13362, Q14738 | CALM1, PPP2R5C, PPP2R5D | More | | Disopyramide | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Disopyramide | hsa04137 | Mitophagy - animal | 3.55E-04 | 4 | Q96CV9, Q9H1Y0, P18848, O43524 | OPTN, ATG5, ATF4, FOXO3 | More | | Disopyramide | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Disopyramide | hsa04145 | Phagosome | 2.75E-02 | 4 | Q15080, P14598, P68371, Q13488 | NCF4, NCF1, TUBB2C, TCIRG1 | More | | Disopyramide | hsa04146 | Peroxisome | 4.38E-03 | 4 | O43933, O96011, P56589, P33121 | PEX1, PEX11B, PEX3, ACSL1 | More | | Disopyramide | hsa04152 | AMPK signaling pathway | 1.83E-02 | 3 | Q96RR4, Q13362, Q14738 | CAMKK2, PPP2R5C, PPP2R5D | More | | Disopyramide | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Disopyramide | hsa04217 | Necroptosis | 4.25E-08 | 18 | P01375, P01568, P48023, Q13489, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, Q93077, Q13557, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, HIST1H2AC, CAMK2D, CHMP2A, PPID | More | | Disopyramide | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.22E-02 | 3 | Q13362, Q14738, P0DP23 | PPP2R5C, PPP2R5D, CALM1 | More | | Disopyramide | hsa04613 | Neutrophil extracellular trap formation | 4.19E-07 | 17 | P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q6FI13, P58876, Q16778, O60814, Q15080, P20160, P08311, P49913, O75015, P21730, P21462 | ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC18; H2AC19, H2BC5, HIST2H2BE, H2BC12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1 | More | | Disopyramide | hsa04621 | NOD-like receptor signaling pathway | 2.77E-03 | 8 | Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Disopyramide | hsa04623 | Cytosolic DNA-sensing pathway | 3.15E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Disopyramide | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-02 | 4 | P17252, O60880, P26717, P26715 | PRKCA, SH2D1A, KLRC2, KLRC1 | More | | Disopyramide | hsa04657 | IL-17 signaling pathway | 4.87E-02 | 2 | P07900, P01584 | HSP90AA1, IL1B | More | | Disopyramide | hsa04713 | Circadian entrainment | 1.69E-02 | 3 | P17252, P48058, P22694 | PRKCA, GRIA4, PRKACB | More | | Disopyramide | hsa04714 | Thermogenesis | 3.16E-02 | 3 | P22694, P33121, Q16718 | PRKACB, ACSL1, NDUFA5 | More | | Disopyramide | hsa04721 | Synaptic vesicle cycle | 6.59E-04 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Disopyramide | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Disopyramide | hsa04723 | Retrograde endocannabinoid signaling | 1.20E-03 | 4 | P17252, P48058, P22694, Q16718 | PRKCA, GRIA4, PRKACB, NDUFA5 | More | | Disopyramide | hsa04724 | Glutamatergic synapse | 1.31E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Disopyramide | hsa04726 | Serotonergic synapse | 2.62E-02 | 3 | P22694, P17252, P31645 | PRKACB, PRKCA, SLC6A4 | More | | Disopyramide | hsa04728 | Dopaminergic synapse | 2.66E-02 | 3 | Q13362, Q14738, P0DP23 | PPP2R5C, PPP2R5D, CALM1 | More | | Disopyramide | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | | Disopyramide | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Disopyramide | hsa04911 | Insulin secretion | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Disopyramide | hsa04913 | Ovarian steroidogenesis | 1.28E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Disopyramide | hsa04918 | Thyroid hormone synthesis | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Disopyramide | hsa04921 | Oxytocin signaling pathway | 3.13E-02 | 3 | P0DP23, Q96RR4, Q13469 | CALM1, CAMKK2, NFATC2 | More | | Disopyramide | hsa04925 | Aldosterone synthesis and secretion | 9.86E-03 | 3 | P17252, P22694, P20020 | PRKCA, PRKACB, ATP2B1 | More | | Disopyramide | hsa04932 | Non-alcoholic fatty liver disease | 6.43E-04 | 7 | P01375, P49841, P18848, P48023, P01584, P13073, O15239 | TNF, GSK3B, ATF4, FASLG, IL1B, COX4I1, NDUFA1 | More | | Disopyramide | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Disopyramide | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Disopyramide | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Disopyramide | hsa04970 | Salivary secretion | 7.14E-03 | 3 | P22694, P20020, P17252 | PRKACB, ATP2B1, PRKCA | More | | Disopyramide | hsa04972 | Pancreatic secretion | 1.48E-03 | 2 | P20020, P17252 | ATP2B1, PRKCA | More | | Disopyramide | hsa04976 | Bile secretion | 3.01E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Disopyramide | hsa04979 | Cholesterol metabolism | 1.61E-02 | 2 | P38571, P61916 | LIPA, NPC2 | More | | Disopyramide | hsa05010 | Alzheimer disease | 7.11E-03 | 9 | O15239, P13073, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Disopyramide | hsa05012 | Parkinson disease | 1.67E-03 | 8 | O15239, P13073, P05141, P12236, P18848, P28070, P43686, Q13557 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ATF4, PSMB4, PSMC4, CAMK2D | More | | Disopyramide | hsa05016 | Huntington disease | 4.79E-05 | 8 | O15239, P13073, Q9GZM3, P30876, P62487, P52435, P05141, Q9NYC9 | NDUFA1, COX4I1, POLR2J2, POLR2B, POLR2G, POLR2J, SLC25A5, DNAH9 | More | | Disopyramide | hsa05017 | Spinocerebellar ataxia | 4.66E-02 | 4 | P28070, P43686, P05141, P12236 | PSMB4, PSMC4, SLC25A5, SLC25A6 | More | | Disopyramide | hsa05020 | Prion disease | 1.94E-05 | 13 | P13591, P01584, P46531, P11142, O15239, P13073, P18848, P05141, P12236, P28070, P43686, P67870, P51636 | NCAM1, IL1B, NOTCH1, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, CSNK2B, CAV2 | More | | Disopyramide | hsa05022 | Pathways of neurodegeneration - multiple diseases | 7.72E-05 | 17 | P67870, O15239, Q16718, P13073, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, O15169, P01584, Q08752, Q13557, P28070, P43686 | CSNK2B, NDUFA1, NDUFA5, COX4I1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, IL1B, PPID, CAMK2D, PSMB4, PSMC4 | More | | Disopyramide | hsa05031 | Amphetamine addiction | 1.69E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Disopyramide | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Disopyramide | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Disopyramide | hsa05110 | Vibrio cholerae infection | 3.01E-02 | 2 | P17252, P22694 | PRKCA, PRKACB | More | | Disopyramide | hsa05131 | Shigellosis | 3.32E-03 | 9 | P01375, O00463, Q04759, Q9UDY8, Q9H1Y0, P20810, O43524, P10415, Q96A32 | TNF, TRAF5, PRKCQ, MALT1, ATG5, CAST, FOXO3, BCL2, MYLPF | More | | Disopyramide | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Disopyramide | hsa05140 | Leishmaniasis | 1.56E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | Disopyramide | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Disopyramide | hsa05144 | Malaria | 9.55E-04 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Disopyramide | hsa05150 | Staphylococcus aureus infection | 8.69E-04 | 5 | P21730, P21462, O75015, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA4, CAMP | More | | Disopyramide | hsa05152 | Tuberculosis | 7.83E-04 | 7 | O75015, P48382, O60603, P01375, P10415, P49913, Q9UDY8 | FCGR3B, RFX5, TLR2, TNF, BCL2, CAMP, MALT1 | More | | Disopyramide | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Disopyramide | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Disopyramide | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.82E-02 | 3 | P23458, Q13469, P0DP23 | JAK1, NFATC2, CALM1 | More | | Disopyramide | hsa05168 | Herpes simplex virus 1 infection | 3.38E-03 | 12 | P25963, P01568, Q05823, P42224, Q07955, Q13243, Q13489, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS5, BIRC3, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | | Disopyramide | hsa05171 | Coronavirus disease - COVID-19 | 4.28E-06 | 17 | P01584, P23396, P62753, P25398, P62249, P42677, P40429, P36578, Q02878, P62917, P32969, Q07020, P46776, P62910, P18077, P05386, P62829 | IL1B, RPS3, RPS6, RPS12, RPS16, RPS27, RPL13A, RPL4, RPL6, RPL8, RPL9, RPL18, RPL27A, RPL32, RPL35A, RPLP1, RPL23 | More | | Disopyramide | hsa05202 | Transcriptional misregulation in cancer | 1.24E-02 | 4 | P27930, P11215, Q13547, P12980 | IL1R2, ITGAM, HDAC1, LYL1 | More | | Disopyramide | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Disopyramide | hsa05212 | Pancreatic cancer | 4.16E-02 | 2 | Q15311, P23458 | RALBP1, JAK1 | More | | Disopyramide | hsa05224 | Breast cancer | 3.88E-02 | 3 | P46531, Q9UM47, O15169 | NOTCH1, NOTCH3, AXIN1 | More | | Disopyramide | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | | Disopyramide | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Disopyramide | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Disopyramide | hsa05415 | Diabetic cardiomyopathy | 1.14E-04 | 10 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P13073, Q13557, P04406 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, COX4I1, CAMK2D, GAPDH | More | | |